The company primarily trades and manufactures calcium carbonate, an inorganic mineral used as a filler and whitening agent in industries such as toothpaste, plastics, rubber, and paints.
The company operates in a highly fragmented, commodity-driven market where transportation costs are the primary competitive factor. Financial metrics contradict any moat claim, with revenue and EPS in steep decline and interest coverage ratios turning negative, indicating a total lack of pricing power or cost advantage.
Capital allocation has been poor, characterized by the closure of non-viable plants and a heavy reliance on unsecured loans from promoters and associates to fund operations. The company has high debt-to-equity levels and is unable to generate sufficient returns to cover its interest obligations.
The company's collapse was a slow-motion train wreck driven by a lethal combination of shrinking revenue and a debt-heavy capital structure. As interest coverage remained negative, the business became a 'zombie' entity, surviving only on the life support of promoter loans. Eventually, the weight of unrecognized MSME liabilities and pending tax litigations crystallized into actual cash outflows, exhausting the remaining liquidity. With the primary manufacturing plant already closed and no pricing power in a commoditized market, the company was unable to pivot, leading to a total erosion of shareholder equity as creditors and promoters took precedence in the inevitable restructuring.
RichFakir rates Lime Chemicals Ltd's business quality as poor — 10/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Lime Chemicals Ltd is trading about 36% above our estimate of fair value; we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Lime Chemicals Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Lime Chemicals Ltd's fair value is about ₹10 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →